Impax Global Equity Opportunities Fund A EUR AccRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 18.3 | 20.6 | -8.7 | 9.6 | 8.8 | |
+/-Cat | -5.3 | 6.1 | 9.3 | -6.4 | -2.6 | |
+/-B’mrk | - | 2.6 | 10.2 | -12.7 | -8.1 | |
Category: Global Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar Gbl Growth TME ... |
Key Stats | ||
NAV 20/11/2024 | EUR 1.22 | |
Day Change | -0.11% | |
Morningstar Category™ | Global Large-Cap Growth Equity | |
ISIN | IE00BJKWZT20 | |
Fund Size (Mil) 20/11/2024 | GBP 1176.35 | |
Share Class Size (Mil) 20/11/2024 | EUR 101.95 | |
Max Initial Charge | - | |
Ongoing Charge 31/07/2024 | 1.09% |
Investment Objective: Impax Global Equity Opportunities Fund A EUR Acc |
The Fund’s investment objective is to generate long term capital growth through an actively managed portfolio of equities from issuers across global equity markets. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
David Winborne 01/01/2018 | ||
Kirsteen Morrison 01/01/2014 | ||
Inception Date 31/01/2023 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Not Benchmarked | Morningstar Gbl Growth TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Impax Global Equity Opportunities Fund A EUR Acc | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 4.20 |
Mastercard Inc Class A | Financial Services | 3.91 |
Alcon Inc | Healthcare | 3.90 |
Boston Scientific Corp | Healthcare | 3.84 |
Linde PLC | Basic Materials | 3.72 |
Increase Decrease New since last portfolio | ||
Impax Global Equity Opportunities Fund A EUR Acc |